About 6 results found for searched term "BV02" (0.119 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M8238 | BV02 | Others |
| BV02 is an inhibitor of the 14-3-3 scaffolding proteins docking site. | ||
| M10829 | HBF-0259 | Others |
| HBF-0259 is a potent and selective hepatitis B virus (HBV) surface antigen (HBsAg) secretion inhibitor in HepG2.2.15 cells EC50 The value is 1.5 μM. HBF-0259 has no effect on HBV DNA synthesis. | ||
| M27630 | Azvudine | Reverse Transcriptase |
| RO-0622; FNC | ||
| Azvudine (RO-0622) is a potent nucleoside reverse transcriptase inhibitor (NRTI), with antiviral activity on HIV, HBV and HCV. Azvudine exerts highly potent inhibition on HIV-1 (EC50s ranging from 0.03 to 6.92 nM) and HIV-2 (EC50s ranging from 0.018 to 0.025 nM). Azvudine inhibits NRTI-resistant viral strains. | ||
| M28185 | Azvudine hydrochloride | Reverse Transcriptase |
| RO-0622 hydrochloride; FNC hydrochloride | ||
| Azvudine (RO-0622) hydrochloride is a potent nucleoside reverse transcriptase inhibitor (NRTI), with antiviral activity on HIV, HBV and HCV. Azvudine hydrochloride exerts highly potent inhibition on HIV-1 (EC50s ranging from 0.03 to 6.92 nM) and HIV-2 (EC50s ranging from 0.018 to 0.025 nM). Azvudine hydrochloride inhibits NRTI-resistant viral strains. | ||
| M29327 | Inarigivir ammonium | Anti-infection |
| ORI-9020 ammonium; SB-9000 ammonium | ||
| Inarigivir (ORI-9020) ammonium is a dinucleotide antiviral drug that can significantly reduce liver HBV DNA in transgenic mice expressing hepatitis B virus. Inarigivir (ORI-9020) ammonium acts as a RIG-I (Retinoic acid-inducible gene-I) agonist to activate cellular innate immune responses. | ||
| M30140 | Inarigivir | Anti-infection |
| ORI-9020; SB-9000 | ||
| Inarigivir (ORI-9020) is a dinucleotide antiviral drug that can significantly reduce liver HBV DNA in transgenic mice expressing hepatitis B virus. Inarigivir (ORI-9020) act as a RIG-I agonist to activate cellular innate immune responses. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
